Translational metagenomics and the human resistome: confronting the menace of the new millennium

J Mol Med (Berl). 2017 Jan;95(1):41-51. doi: 10.1007/s00109-016-1478-0. Epub 2016 Oct 20.

Abstract

The increasing threat of antimicrobial resistance poses one of the greatest challenges to modern medicine. The collection of all antimicrobial resistance genes carried by various microorganisms in the human body is called the human resistome and represents the source of resistance in pathogens that can eventually cause life-threatening and untreatable infections. A deep understanding of the human resistome and its multilateral interaction with various environments is necessary for developing proper measures that can efficiently reduce the spread of resistance. However, the human resistome and its evolution still remain, for the most part, a mystery to researchers. Metagenomics, particularly in combination with next-generation-sequencing technology, provides a powerful methodological approach for studying the human microbiome as well as the pathogenome, the virolume and especially the resistome. We summarize below current knowledge on how the human resistome is shaped and discuss how metagenomics can be employed to improve our understanding of these complex processes, particularly as regards a rapid translation of new findings into clinical diagnostics, infection control and public health.

Keywords: Antibiotic selection pressure; Antimicrobial resistance; Bacteriophages; Clinical diagnostics; Next generation sequencing; Public health.

Publication types

  • Review

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • Anti-Bacterial Agents / therapeutic use
  • Bacterial Infections / diagnosis
  • Bacterial Infections / drug therapy
  • Bacterial Infections / microbiology
  • Drug Resistance, Microbial*
  • Humans
  • Infection Control
  • Metagenome*
  • Metagenomics* / methods
  • Microbiota / drug effects*
  • Microbiota / genetics*
  • Translational Research, Biomedical

Substances

  • Anti-Bacterial Agents